Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy

  • Authors:
    • Qiu-Ming Wang
    • Zhi-Jun Duan
    • Jian-Ling Du
    • Shi-Bin Guo
    • Xiao-Yu Sun
    • Zhen Liu
  • View Affiliations

  • Published online on: March 20, 2013     https://doi.org/10.3892/ijmm.2013.1309
  • Pages: 1186-1194
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Splenectomy is a recognized therapy for liver cirrhosis with splenomegaly, since it decreases free iron concentration that accompanies the destruction of red blood cells. Heme oxygenase (HO)-1 and its by-products, iron and carbon monoxide (CO), play crucial roles in hepatic fibrosis. The aim of the present study was to determine whether splenectomy in cirrhotic rats induced by bile duct ligation (BDL), through the HO/CO pathway, could slow down the development of liver fibrosis. Male Sprague-Dawley rats were divided randomly into the sham, BDL, splenectomy, Fe, zinc protoporphyrin (Znpp) and cobalt protoporphyrin (Copp) treatment groups, for inhibiting and inducing HO-1 expression. The level of HO-1 was detected by western blot analysis and reverse transcription-polymerase chain reaction. Serum carboxyhemoglobin (COHb), iron and portal vein pressure (PVP) were also quantified. Liver iron was measured by atomic absorption spectrometry with acetylene-air flame atomization. HO-1 and α-smooth muscle actin (α-SMA) were localized by immunohistochemistry. Liver and spleen iron were visualized by Perls' Prussian blue staining. Hepatic fibrosis was assessed using hematoxylin and eosin (H&E) staining. Enzyme-linked immunosorbent assay (ELISA) was used to detect serum transforming growth factor-β1 (TGF-β1). The results showed that liver, spleen and serum levels of HO-1, COHb and iron were greatly enhanced in the BDL group compared with the sham group; they were reduced following splenectomy and Znpp treatment, but were elevated in the Copp and Fe groups. Hydroxyproline, TGF-β1, α-SMA, PVP and malonaldehyde levels were lower in the splenectomy and Znpp groups compared to BDL, while higher levels were observed in the Copp and Fe-treated groups. Our study shows that splenectomy reduces iron and CO levels in part by reducing HO-1 expression, and it decreases portal pressure and slightly decreases hepatic fibroproliferation.
View Figures
View References

Related Articles

Journal Cover

May 2013
Volume 31 Issue 5

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Wang Q, Duan Z, Du J, Guo S, Sun X and Liu Z: Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy. Int J Mol Med 31: 1186-1194, 2013
APA
Wang, Q., Duan, Z., Du, J., Guo, S., Sun, X., & Liu, Z. (2013). Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy. International Journal of Molecular Medicine, 31, 1186-1194. https://doi.org/10.3892/ijmm.2013.1309
MLA
Wang, Q., Duan, Z., Du, J., Guo, S., Sun, X., Liu, Z."Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy". International Journal of Molecular Medicine 31.5 (2013): 1186-1194.
Chicago
Wang, Q., Duan, Z., Du, J., Guo, S., Sun, X., Liu, Z."Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy". International Journal of Molecular Medicine 31, no. 5 (2013): 1186-1194. https://doi.org/10.3892/ijmm.2013.1309